Molecule Details
InChIKeyPKCDDUHJAFVJJB-VLZXCDOPSA-N
Canonical SMILESC[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)13
Pfam Stratification Cross-Family
Avg pChEMBL7.02
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB06075
Drug NameLinsitinib
CAS Number867160-71-2
Groups investigational
ATC Codes nan
DescriptionAn orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. IGF-1R inhibitor OSI-906 selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis...

Cross-references: BindingDB: 50315887 CHEMBL1091644 Wikipedia: Linsitinib ZINC: ZINC000100071817
Target Activities (13)
Target Gene Organism Category Pfam pChEMBL Type Source
Q15759 MAPK11 Homo sapiens Human PF00069 8.0 Kd ChEMBL
P08069 IGF1R Homo sapiens Human PF00757 PF07714 PF01030 7.7 IC50 ChEMBL;BindingDB
P27361 MAPK3 Homo sapiens Human PF00069 7.5 IC50 ChEMBL
P28482 MAPK1 Homo sapiens Human PF00069 7.5 IC50 ChEMBL
P06213 INSR Homo sapiens Human PF00757 PF17870 PF07714 PF01030 7.3 IC50 ChEMBL;BindingDB
Q12851 MAP4K2 Homo sapiens Human PF00780 PF00069 7.2 Kd ChEMBL
P14616 INSRR Homo sapiens Human PF00041 PF00757 PF07714 PF01030 7.1 IC50 ChEMBL
O95835 LATS1 Homo sapiens Human PF00069 PF00433 PF00627 6.7 Kd ChEMBL
Q3MIX3 ADCK5 Homo sapiens Human PF03109 6.7 Kd ChEMBL
P36888 FLT3 Homo sapiens Human PF00047 PF07714 6.5 Kd ChEMBL
Q02750 MAP2K1 Homo sapiens Human PF00069 6.5 Kd ChEMBL
P08581 MET Homo sapiens Human PF07714 PF01437 PF01403 PF01833 6.4 Kd ChEMBL
Q9Y4K4 MAP4K5 Homo sapiens Human PF00780 PF00069 6.2 Kd ChEMBL
DrugBank Target Actions (2)
Target Gene Target Name Action Type
P06213 INSR Insulin receptor inhibitor targets
P08069 IGF1R Insulin-like growth factor 1 receptor inhibitor targets